Analysis of echocardiographic parameters of cardiac function in patients with acute stroke
Abstract
Introduction. Cardiologic diagnostics in stroke patients is designed to identify heart disease as a potential cause of stroke. The aim of this study was to evaluate the effect of low ejection fraction (EF) and left ventricular systolic/diastolic dysfunction (LVSD, LVDD) on the neurological state on the 1st day of stroke, as well as post-stroke functional status at 30 days after stroke.
Patients and methods. For a prospective study, 162 stroke patients (mean age 74 years) were qualified. They were analysed according to neurological state on the 1st day of stroke, the results of transthoracic echocardiography, and functional status at 30 days after stroke.
Results. The neurological state on the 1st day after stroke was significantly worse in patients with LVSD. In patients with reduced EF, functional status was significantly worse at 30 days after stroke. Patients with E/A 0.8–2 had a significantly worse functional status compared to patients with E/A < 0.8. Individuals with E/A 0.8–2 and segmental LVSD or EF < 50% had significantly worse functional status compared to patients without LVSD. An independent factor for moderate/severe status was identified: E/A > 0.8 (RR 3.28 [95% CI 1.15-9.37]); independent factors for poor functional status were lower EF (RR 4.68 [95% CI 1.22–18.00]) and age (RR 4.68 [95% CI 1.22–11.00]).
Conclusions. One quarter of patients in the acute phase of stroke have LVSD and/or LVDD. LVSD adversely affects both neurological status in acute stroke as well as functional status in the short-term follow-up. Age at first-in-life stroke incidence and lower EF are predictors of poor functional status one month after a stroke.
Keywords: strokecardiac dysfunctionfraction ejectionmRankin
References
- Murray C, Lopez A. Measuring the Global Burden of Disease. New England Journal of Medicine. 2013; 369(5): 448–457.
- Sandhu RK, Hohnloser SH, Pfeffer MA, et al. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure. Stroke. 2015; 46(3): 667–672.
- Granger C, Alexander J, McMurray J, et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. New England Journal of Medicine. 2011; 365(11): 981–992.
- Liakos CI, Grassos CA, Babalis DK, et al. European Society of Hypertension, European Society of Cardiology. 2013 ESH/ESC guidelines for the management of arterial hypertension: what has changed in daily clinical practice? High Blood Press Cardiovasc Prev. 2015; 22(1): 43–53.
- Gionfriddo MR, McCoy RG, Lipska KJ. The 2013 American Association of Clinical Endocrinologists' diabetes mellitus management recommendations: improvements needed. JAMA Intern Med. 2014; 174(2): 179–180.
- Catapano A, Graham I, Backer GDe, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016; 37(39): 2999–3058.
- Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis. New England Journal of Medicine. 1991; 325(7): 445–453.
- Betti I, Castelli G, Barchielli A, et al. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J Card Fail. 2009; 15(5): 377–384.
- Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J. 1999; 20(6): 447–455.
- McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997; 350(9081): 829–833.
- Kelly R, Struthers AD. Screening for left ventricular systolic dysfunction in patients with stroke, transient ischaemic attacks, and peripheral vascular disease. QJM. 1999; 92(6): 295–297.
- Asrar Ul Haq M, Goh CY, Levinger I, et al. Clinical utility of exercise training in heart failure with reduced and preserved ejection fraction. Clin Med Insights Cardiol. 2015; 9: 1–9.
- How to diagnose diastolic heart failure. European Heart Journal. 1998; 19(7): 990–1003.
- Echocardiographic Predictors of Stroke in Patients With Atrial Fibrillation. Archives of Internal Medicine. 1998; 158(12): 1316.
- Hachet O, Guenancia C, Stamboul K, et al. Frequency and predictors of stroke after acute myocardial infarction: specific aspects of in-hospital and postdischarge events. Stroke. 2014; 45(12): 3514–3520.
- Kim D, Shim C, Hong GR, et al. Clinical Implications and Determinants of Left Atrial Mechanical Dysfunction in Patients With Stroke. Stroke. 2016; 47(6): 1444–1451.
- Park HK, Kim BJ, Yoon CH, et al. Left Ventricular Diastolic Dysfunction in Ischemic Stroke: Functional and Vascular Outcomes. J Stroke. 2016; 18(2): 195–202.
- Pullicino P, Mifsud V, Wong E, et al. Hypoperfusion-related cerebral ischemia and cardiac left ventricular systolic dysfunction. J Stroke Cerebrovasc Dis. 2001; 10(4): 178–182.
- Zannad F, Stough WG, Regnault V, et al. Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. Int J Cardiol. 2013; 167(5): 1772–1782.
- Shantsila E, Wrigley BJ, Blann AD, et al. A contemporary view on endothelial function in heart failure. Eur J Heart Fail. 2012; 14(8): 873–881.
- Yilmaz R, Demirbag R, Durmus I, et al. Association of stage of left ventricular diastolic dysfunction with P wave dispersion and occurrence of atrial fibrillation after first acute anterior myocardial infarction. Ann Noninvasive Electrocardiol. 2004; 9(4): 330–338.
- Seo JY, Lee KB, Lee JG, et al. Implication of left ventricular diastolic dysfunction in cryptogenic ischemic stroke. Stroke. 2014; 45(9): 2757–2761.
- Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med. 2002; 137(8): 631–639.
- Hays AG, Sacco RL, Rundek T, et al. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke. 2006; 37(7): 1715–1719.
- Witt BJ, Brown RD, Jacobsen SJ, et al. Ischemic stroke after heart failure: a community-based study. Am Heart J. 2006; 152(1): 102–109.
- Freudenberger R, Hellkamp A, Halperin J, et al. Risk of Thromboembolism in Heart Failure. Circulation. 2007; 115(20): 2637–2641.
- Di Tullio MR, Qian M, Thompson JLP, et al. WARCEF Investigators. Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial. Stroke. 2016; 47(8): 2031–2037.
- Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke. 2003; 34(1): 122–126.
- Ois A, Gomis M, Cuadrado-Godia E, et al. Heart failure in acute ischemic stroke. Journal of Neurology. 2008; 255(3): 385–389.
- Abdul-Rahim AH, Fulton RL, Frank B, et al. VISTA collaborators. Associations of chronic heart failure with outcome in acute ischaemic stroke patients who received systemic thrombolysis: analysis from VISTA. Eur J Neurol. 2015; 22(1): 163–169.
- Burkot J, Kopec G, Pera J, et al. Decompensated Heart Failure Is a Strong Independent Predictor of Functional Outcome After Ischemic Stroke. J Card Fail. 2015; 21(8): 642–646.
![](https://journals.viamedica.pl/plugins/generic/popups/images/icons/close.png)